Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
MBF-015 by Medibiofarma for Huntington Disease: Likelihood of Approval
MBF-015 is under clinical development by Medibiofarma and currently in Phase II for Huntington Disease. According to GlobalData, Phase II...
Data Insights
MBF-015 by Medibiofarma for Huntington Disease: Likelihood of Approval
MBF-015 is under clinical development by Medibiofarma and currently in Phase II for Huntington Disease. According to GlobalData, Phase II...